18.08.01 · organismal-bio / renal

Renal physiology — homeostasis and the nephron

draft3 tiersLean: none

Anchor (Master): Boron-Boulpaep advanced sections; Brenner and Rector The Kidney 11th ed.; primary literature — Bowman 1842, Starling 1896, Richards 1930s, Kuhn and Ramel 1959

Intuition [Beginner]

The kidneys maintain the internal environment of the body. Every day, they filter about 180 litres of blood plasma, selectively reabsorb the useful components (water, glucose, amino acids, ions), and excrete the waste products (urea, creatinine, excess ions) in about 1.5-2 litres of urine.

The functional unit of the kidney is the nephron. Each kidney contains about one million nephrons. A nephron has two main parts: a glomerulus, where filtration occurs, and a renal tubule, where the filtered fluid is processed.

Filtration in the glomerulus is like pouring blood through a very fine sieve. Blood pressure forces water and small solutes out of the capillaries and into the tubule. Blood cells and large proteins are too big to pass through and remain in the blood. The result is an ultrafiltrate that has nearly the same composition as blood plasma minus the proteins.

The tubule then modifies this ultrafiltrate. Most of the water and solutes are reabsorbed back into the blood. Additional substances are secreted from the blood into the tubule for excretion. By the end of the tubule, the 180 litres of filtrate have been reduced to about 1.5 litres of urine with a composition very different from blood plasma.

The kidneys regulate blood volume, blood pressure, electrolyte balance, and acid-base balance. They also produce hormones: erythropoietin (stimulates red blood cell production) and renin (initiates the RAAS cascade for blood pressure regulation).

Visual [Beginner]

The nephron can be drawn as a long, winding tube with distinct segments. Fluid enters at the glomerulus (Bowman's capsule), flows through the proximal convoluted tubule, down the descending limb of the loop of Henle, up the ascending limb, through the distal convoluted tubule, and into the collecting duct, which drains into the renal pelvis and eventually the bladder.

Nephron structure showing glomerulus, proximal tubule, loop of Henle, distal tubule, and collecting duct. Arrows indicate the direction of fluid flow. The vasa recta (capillary network) runs alongside the loop of Henle.

The loop of Henle creates a concentration gradient in the kidney's medulla. The descending limb is permeable to water but not to solutes; the ascending limb is permeable to solutes but not to water. This counter-current arrangement produces a gradient from 300 mOsm at the cortex to 1200 mOsm at the inner medulla.

Worked example [Beginner]

Calculate daily urine output given typical filtration and reabsorption rates.

Given: GFR = 125 mL/min, 99% of filtrate is reabsorbed.

Step 1. Calculate daily filtrate volume:

Step 2. If 99% is reabsorbed, 1% is excreted:

This matches typical urine output of 1.5-2.0 litres per day. The kidney reabsorbs 178.2 litres of the 180 litres filtered, demonstrating the enormous efficiency of tubular reabsorption.

Check your understanding [Beginner]

Formal definition [Intermediate+]

Glomerular filtration

Glomerular filtration rate (GFR) is the volume of plasma filtered per unit time. It is determined by the balance of Starling forces across the glomerular capillary wall:

where is the filtration coefficient (product of hydraulic permeability and surface area), is the hydrostatic pressure difference favouring filtration, and is the oncotic pressure difference opposing filtration.

Normal values: glomerular capillary hydrostatic pressure ~55 mmHg, Bowman's capsule hydrostatic pressure ~15 mmHg, glomerular capillary oncotic pressure ~30 mmHg, Bowman's capsule oncotic pressure ~0 mmHg (proteins are not filtered). Net filtration pressure = 55 - 15 - 30 + 0 = 10 mmHg.

The oncotic pressure inside the glomerular capillary is not constant along its length. As plasma is filtered and protein-free fluid leaves the capillary, the protein concentration in the remaining plasma rises, increasing progressively from about 20 mmHg at the afferent end to about 35 mmHg at the efferent end. Filtration therefore occurs predominantly in the first half of the glomerular capillary, where is positive; toward the efferent end, filtration equilibrium may be reached where the net driving force falls to zero and filtration ceases. This rising oncotic pressure is the reason that the net filtration pressure is only about 10 mmHg on average despite a much larger initial hydrostatic driving force.

GFR is regulated by adjusting the afferent and efferent arteriolar resistances. Constriction of the afferent arteriole reduces glomerular pressure and GFR. Constriction of the efferent arteriole increases glomerular pressure and GFR (up to a point, beyond which the increased post-glomerular resistance raises enough to reduce net filtration). The balance of these resistances maintains GFR relatively constant over a range of systemic blood pressures (autoregulation).

Tubular transport

The renal tubule performs three key operations on the ultrafiltrate delivered to it from Bowman's capsule.

Reabsorption is the transport of substances from tubular fluid back into the peritubular capillary blood. The proximal tubule reabsorbs approximately 65% of filtered Na+, water (isosmotically, following the sodium), K+, Ca2+, HCO3-, and 100% of filtered glucose and amino acids. This massive reabsorption occurs through a combination of transcellular and paracellular pathways: sodium enters the proximal tubule cell across the apical membrane via cotransporters (SGLT for glucose, various amino acid cotransporters) and exchangers (Na+/H+ antiport via NHE3), then exits across the basolateral membrane via the Na+/K+ ATPase. Water follows osmotically through aquaporin-1 channels and the paracellular route. The peritubular capillaries, with their low hydrostatic pressure and high oncotic pressure (a consequence of glomerular filtration having concentrated the plasma proteins), provide a favourable Starling-force environment for uptake of the reabsorbed fluid.

Secretion is the transport of substances from peritubular blood into the tubular fluid. Secretion is the primary route for eliminating many organic acids (e.g., PAH, urate), organic bases, drug metabolites, and certain toxins. The proximal tubule secretes these via organic anion transporters (OAT1/3) and organic cation transporters (OCT2) on the basolateral side, coupled to MDR and MRP efflux pumps on the apical side. Secretion of K+ and H+ in the distal nephron is hormonally regulated and is the primary determinant of potassium and acid-base balance.

Concentration or dilution is accomplished by the loop of Henle and collecting ducts, which adjust final urine osmolarity from 50 mOsm (very dilute) to 1200 mOsm (very concentrated), depending on water intake and ADH levels.

Transport processes are limited by transport maximum (Tm) values. For glucose, Tm is about 375 mg/min. When the filtered glucose load exceeds Tm (as in hyperglycaemia), excess glucose appears in the urine. The relationship between plasma glucose and urinary glucose excretion is sigmoid rather than sharp: some nephrons begin spilling glucose at lower loads than others because of nephron heterogeneity, producing a "splay" region around the threshold.

Counter-current mechanism

The counter-current multiplier (loop of Henle) establishes the medullary osmotic gradient through the interaction of three tubular segments with distinct permeability properties arranged in a hairpin configuration.

The descending limb is permeable to water but has very low permeability to solutes. As tubular fluid descends into the increasingly hypertonic medullary interstitium, water exits by osmosis and the tubular fluid becomes progressively more concentrated, reaching approximately 1200 mOsm at the papillary tip.

The thin ascending limb is impermeable to water but permeable to NaCl. NaCl diffuses passively down its concentration gradient from the concentrated tubular fluid into the interstitium, diluting the tubular fluid. This passive efflux is driven by the concentration gradient established in the descending limb.

The thick ascending limb is impermeable to water and actively transports NaCl out via the Na-K-2Cl cotransporter (NKCC2), powered by the basolateral Na+/K+ ATPase. This active transport constitutes the "single effect" — the ability to separate solute from water at any given level of the medulla. The counter-current flow arrangement multiplies this single effect along the length of the loop, producing a gradient from 300 mOsm at the corticomedullary junction to 1200 mOsm at the inner medulla.

The counter-current exchanger (vasa recta) preserves the medullary gradient. These hairpin-shaped capillaries descend into the medulla alongside the loop of Henle. As blood descends, it gains solute and loses water, equilibrating with the increasingly hypertonic interstitium. As blood ascends back toward the cortex, the reverse occurs: it loses solute and gains water. The net effect is that blood flowing through the vasa recta picks up relatively little net solute, so the gradient is maintained. High medullary blood flow (as occurs with osmotic diuresis or vasodilation) overwhelms this protective mechanism and washes out the gradient.

RAAS

The renin-angiotensin-aldosterone system regulates blood pressure and sodium balance through a multi-step enzymatic cascade. Decreased renal perfusion pressure, decreased NaCl delivery to the macula densa, or sympathetic nervous system activation stimulates renin release from the juxtaglomerular cells of the afferent arteriole. Renin is an aspartyl protease that cleaves angiotensinogen (a large globular protein synthesised by the liver) to produce the decapeptide angiotensin I.

Angiotensin-converting enzyme (ACE), a zinc metallopeptidase located primarily on the endothelial surface of pulmonary capillaries, converts angiotensin I to the octapeptide angiotensin II by removing two C-terminal residues. Angiotensin II is one of the most potent physiological vasoconstrictors known, active at nanomolar concentrations. Its actions include: (a) arteriolar vasoconstriction throughout the systemic circulation, raising total peripheral resistance and hence blood pressure; (b) stimulation of aldosterone release from the zona glomerulosa of the adrenal cortex; (c) stimulation of ADH release from the posterior pituitary; (d) stimulation of thirst via the subfornical organ in the hypothalamus; and (e) preferential constriction of the efferent arteriole in the kidney, which maintains glomerular capillary pressure and GFR when systemic pressure is falling.

Aldosterone is a mineralocorticoid that acts on principal cells of the distal convoluted tubule and collecting duct. It enters the cell, binds to the mineralocorticoid receptor, translocates to the nucleus, and upregulates transcription of the epithelial sodium channel (ENaC), the basolateral Na+/K+ ATPase, and the apical potassium channel (ROMK). The net effect is increased Na+ reabsorption, increased K+ secretion, and increased H+ secretion. Aldosterone-mediated sodium retention expands extracellular fluid volume and supports blood pressure.

Acid-base balance

The kidneys regulate blood pH through three mechanisms. First, they reabsorb virtually all filtered bicarbonate () in the proximal tubule via a mechanism that couples apical Na+/H+ exchange (NHE3) with intracellular carbonic anhydrase (CA-II) and basolateral Na+/HCO3-/CO3(2-) cotransport (NBCe1). For each bicarbonate reabsorbed, one H+ is secreted into the lumen where it combines with filtered HCO3- to form CO2 and water (catalysed by apical carbonic anhydrase IV); the CO2 diffuses back into the cell and is rehydrated to generate new H+ and HCO3-.

Second, the kidneys generate new bicarbonate via titratable acid excretion. Secreted H+ that does not combine with bicarbonate is instead buffered by urinary phosphate (), and the resulting is excreted as titratable acid. Each mole of titratable acid excreted corresponds to one mole of new bicarbonate returned to the blood.

Third, the kidneys generate new bicarbonate via ammonia excretion. Proximal tubule cells metabolise glutamine to produce and . The is secreted into the lumen (via NHE3 substituting for ) and is eventually excreted in the urine. For each mole of excreted, one mole of new is added to the blood. In chronic metabolic acidosis, ammonium excretion can increase up to tenfold, making it the most important renal compensatory mechanism for sustained acid-base disturbances.

Key theorem with proof [Intermediate+]

Theorem (GFR independence from systemic pressure within the autoregulatory range). Over the range of mean arterial pressure from 80 to 180 mmHg, GFR remains nearly constant due to autoregulation of afferent and efferent arteriolar tone. This mechanism protects the glomerular capillaries from pressure damage while maintaining stable filtration.

Proof. The net filtration pressure is , where is glomerular capillary pressure. depends on systemic arterial pressure (), afferent resistance (), and efferent resistance ():

When rises, the afferent arteriole constricts (increasing ), which dissipates the extra pressure across the afferent arteriole and keeps nearly constant. Simultaneously, the efferent arteriole may dilate slightly (decreasing ). The combined effect buffers from changes in .

This myogenic response (stretch-induced vasoconstriction mediated by vascular smooth muscle responding directly to increased transmural pressure) is supplemented by tubuloglomerular feedback: increased NaCl delivery to the macula densa (a consequence of increased GFR) signals the afferent arteriole to constrict, reducing GFR back toward normal. The macula densa, a plaque of specialised tubular cells in the thick ascending limb adjacent to its own glomerulus, senses luminal NaCl concentration via the NKCC2 cotransporter and releases adenosine (or ATP that is metabolised to adenosine) in proportion to the NaCl load. Adenosine constricts the afferent arteriole via A1 receptors. The feedback operates over seconds to minutes.

Below 80 mmHg, autoregulation fails and GFR falls in proportion to pressure. Above 180 mmHg, the arterioles cannot constrict sufficiently and GFR rises. Within the autoregulatory range, GFR varies less than 10% despite large changes in arterial pressure.

Bridge. This autoregulatory theorem builds toward 18.02.01 cardiovascular physiology, where cardiac output and peripheral resistance set the systemic arterial pressure that the kidney must filter against. The foundational reason GFR needs protecting is that the glomerular capillary wall is a delicate trilaminar filtration barrier (fenestrated endothelium, basement membrane, podocyte foot processes) that would be damaged by sustained high pressures. The counter-current multiplier explored in the Master sections is exactly the downstream consequence of stable GFR: a steady delivery of isotonic filtrate to the loop of Henle enables the medullary gradient to be maintained as a standing osmotic column.

Exercises [Intermediate+]

Counter-current exchange and renal concentrating mechanism [Master]

The counter-current multiplier can be analysed formally. Let the single effect (the osmolarity difference the thick ascending limb can establish at any level) be . In a steady state with counter-current flow, the total medullary gradient is amplified to approximately , where is an amplification factor related to the flow rate and tubular geometry. This was first modelled quantitatively by Kuhn and Ramel (1959) [Kuhn & Ramel 1959], who recognised that the kidney's loop of Henle operates on the same principle as an industrial counter-current heat exchanger: a small single-stage separation, repeated along a hairpin geometry with opposing flows, generates a gradient far exceeding what any single stage could produce.

The Kuhn-Ramel model treats the loop of Henle as two parallel tubes (descending and ascending limbs) separated by a membrane with defined solute and water permeabilities, flowing in opposite directions. At each axial position along the medulla, the ascending limb pumps out NaCl at a rate determined by NKCC2 activity, increasing the local interstitial osmolarity by an increment . The descending limb, permeable to water, equilibrates osmotically with the local interstitium, concentrating its contents. The ascending limb at position therefore receives fluid that was concentrated at position (because the flow is ascending, against the direction of increasing interstitial osmolarity), and pumps out NaCl into an interstitium that has already been enriched by all the pumping at positions below . This is the multiplication: each increment of the single effect builds on all the increments below it.

The concentrating ability of the kidney is limited by three factors. First, the maximum osmolarity of the medullary interstitium is set by the counter-current multiplier and the urea recycling pathway. Urea contributes approximately half of the medullary osmolarity at the papillary tip: ADH increases the water permeability of the inner medullary collecting duct (via aquaporin-2 insertion), concentrating urea in the tubular fluid until it diffuses into the medullary interstitium through urea transporter UT-A1. This recycled urea augments the NaCl-derived gradient and is essential for achieving the full 1200 mOsm.

Second, the water permeability of the collecting duct is controlled by ADH. In the absence of ADH, the collecting duct is virtually impermeable to water, and even a fully established medullary gradient cannot concentrate the urine. The ADH-dependent insertion and retrieval of aquaporin-2 channels in the apical membrane of principal cells is the rate-limiting step for water reabsorption and is regulated over a time course of minutes.

Third, the rate of medullary blood flow determines whether the gradient is preserved or washed out. The vasa recta function as efficient counter-current exchangers only when flow is slow. Osmotic diuretics (mannitol, glucose in uncontrolled diabetes) increase medullary blood flow and wash out the gradient, which is one reason why osmotic diuresis produces such large volumes of relatively dilute urine. Loop diuretics (furosemide, bumetanide) block NKCC2 directly, abolishing the single effect and therefore the entire multiplier, producing large volumes of iso-osmotic urine.

The quantitative capacity of the human kidney to concentrate urine is measured by the free water clearance: , where is urine flow rate and is osmolar clearance. A negative free water clearance () indicates that the kidney is producing urine more concentrated than plasma, which requires both an intact counter-current system and adequate ADH. In central diabetes insipidus (ADH deficiency), free water clearance is strongly positive and the kidney excreces large volumes of dilute urine regardless of plasma osmolarity.

Segmental transport: proximal tubule through collecting duct [Master]

Each segment of the nephron has a distinct complement of transport proteins that gives it a characteristic pattern of reabsorption and secretion. Understanding the nephron segment-by-segment is essential because renal disease, pharmacological intervention, and hormonal regulation all act on specific segments with specific transporters.

The proximal convoluted tubule reabsorbs approximately 65% of filtered sodium and water, nearly all filtered glucose and amino acids, 80-90% of filtered bicarbonate, and substantial fractions of filtered phosphate, urate, and citrate. The driving force for virtually all proximal reabsorption is the basolateral Na+/K+ ATPase, which maintains a low intracellular Na+ concentration (~15 mM versus ~140 mM in plasma). This sodium gradient powers secondary active transport across the apical membrane: SGLT2 (in the early S1 segment) and SGLT1 (in the later S3 segment) couple sodium entry to glucose reabsorption; NHE3 (Na+/H+ exchanger 3) couples sodium reabsorption to H+ secretion, which drives bicarbonate reabsorption; and peptide and amino acid cotransporters recover the filtered organic nitrogen load. Water follows sodium osmotically through aquaporin-1 (AQP1) in both the apical and basolateral membranes and through the paracellular route. The proximal tubule is also the primary site of organic anion secretion (PAH, drug conjugates via OAT1/3) and organic cation secretion (via OCT2), which is critical for the elimination of xenobiotics.

A key feature of proximal tubule function is glomerulotubular balance: the absolute rate of proximal reabsorption adjusts to match changes in GFR. If GFR increases, the filtered load of glucose, amino acids, and sodium increases proportionally, and the increased delivery of these solutes to the proximal tubule drives increased coupled sodium reabsorption. This keeps the fractional reabsorption at approximately 65% regardless of the absolute GFR, preventing downstream segments from being overwhelmed by fluctuations in filtrate delivery. The mechanism is partly load-dependent (more solute delivered means more substrate for cotransporters) and partly mediated by peritubular capillary Starling forces (increased filtration raises peritubular oncotic pressure, favouring fluid uptake).

The loop of Henle receives the remaining 35% of the filtrate and reabsorbs approximately 25% of filtered sodium and 15% of filtered water. The descending limb reabsorbs water passively; the thin ascending limb reabsorbs NaCl passively by diffusion; and the thick ascending limb reabsorbs NaCl actively via NKCC2. The thick ascending limb also reabsorbs calcium and magnesium paracellularly, driven by the lumen-positive transepithelial potential difference created by potassium recycling through the apical ROMK channel. This paracellular divalent cation reabsorption is the reason that loop diuretics (which abolish the lumen-positive potential) increase urinary calcium and magnesium excretion.

The distal convoluted tubule receives about 10% of filtered sodium and reabsorbs it via the Na-Cl cotransporter (NCC). This segment is the target of thiazide diuretics, which block NCC and produce modest natriuresis with calciuria (the opposite of loop diuretics — thiazides actually decrease urinary calcium excretion, which is why they are used to treat calcium nephrolithiasis). The distal tubule is relatively impermeable to water and further dilutes the tubular fluid.

The collecting duct system (connecting tubule, cortical collecting duct, and medullary collecting duct) performs the final regulation of urine composition. Principal cells reabsorb sodium via ENaC (epithelial sodium channel) under the control of aldosterone, and secrete potassium via ROMK. The ENaC-mediated sodium reabsorption creates a lumen-negative transepithelial potential that drives potassium and hydrogen ion secretion, which is why aldosterone excess causes hypokalaemia and alkalosis, while aldosterone deficiency causes hyperkalaemia and acidosis. Intercalated cells in the collecting duct handle acid-base regulation: type A intercalated cells secrete H+ via H+-ATPase and reabsorb bicarbonate (active during acidosis), while type B intercalated cells secrete bicarbonate (active during alkalosis). The medullary collecting duct, under ADH control, determines final water reabsorption and therefore final urine concentration.

The segmental organisation of the nephron has a direct clinical correlate in the tubuloglomerular feedback and the juxtaglomerular apparatus. The macula densa cells of the thick ascending limb are in anatomical contact with the extraglomerular mesangium, the afferent and efferent arterioles, and the juxtaglomerular (renin-secreting) cells. This anatomical arrangement transforms the nephron from a passive conduit into a self-regulating unit that can adjust its own filtration rate (via tubuloglomerular feedback) and signal systemic blood pressure status (via renin release).

Integrated sodium and water balance: volume and osmoregulation [Master]

The kidney simultaneously regulates two distinct but interacting variables: extracellular fluid volume (determined primarily by total body sodium) and plasma osmolarity (determined primarily by water balance relative to solute). These two regulatory axes use overlapping but distinguishable sensors, effectors, and hormonal systems. Sodium balance is regulated primarily by the RAAS and atrial natriuretic peptide (ANP), while water balance is regulated primarily by ADH and thirst.

Volume regulation depends on the concept of effective circulating volume — the portion of extracellular fluid that actually perfuses tissues and is sensed by the body's volume receptors. Effective circulating volume is not identical to total extracellular fluid volume: in conditions like congestive heart failure, total body sodium and extracellular fluid are increased (oedema), but the effective circulating volume is reduced because cardiac output is low. The kidney responds to reduced effective circulating volume by retaining sodium via RAAS activation, even though total body sodium is already excessive. This apparently paradoxical response — sodium retention in the setting of oedema — illustrates that the kidney cannot distinguish between "low volume because of true sodium depletion" and "low effective volume because of cardiac pump failure"; it responds to the sensory signal, not the clinical context.

Volume sensors are located in the atria (low-pressure cardiopulmonary baroreceptors that sense central venous pressure), the carotid sinus and aorta (high-pressure arterial baroreceptors that sense arterial pulse pressure), the juxtaglomerular apparatus (sensing renal perfusion pressure and NaCl delivery), and the hepatic portal circulation. Atrial stretch from increased central venous pressure releases ANP, which increases sodium excretion (natriuresis) by closing ENaC channels in the collecting duct, inhibiting renin release, and increasing GFR via afferent arteriolar dilation. Conversely, decreased atrial stretch (as in haemorrhage or dehydration) removes the ANP signal and allows unopposed RAAS activation, producing sodium retention.

Osmoregulation is mediated primarily by osmoreceptors in the organum vasculosum of the lamina terminalis (OVLT) and the subfornical organ (SFO) — circumventricular organs that lack a blood-brain barrier and are therefore directly exposed to plasma osmolarity. These osmoreceptors are specialised neurons that shrink or swell in response to changes in plasma osmolarity: a 1-2% increase in plasma osmolarity (as little as 3 mOsm above the threshold of approximately 280 mOsm) is sufficient to stimulate ADH release from the posterior pituitary. The relationship between plasma osmolarity and plasma ADH concentration is steeply sigmoid, with ADH rising from near-zero at 280 mOsm to maximum levels at approximately 295 mOsm.

ADH (vasopressin) acts on V2 receptors in the basolateral membrane of principal cells in the collecting duct, activating adenylate cyclase, raising intracellular cAMP, and triggering the insertion of aquaporin-2 (AQP2) water channels into the apical membrane. Water then enters the cell through AQP2 and exits basolaterally through AQP3 and AQP4 into the hypertonic medullary interstitium. The effect is rapid: urine osmolarity can change from 50 mOsm to 1000 mOsm within 30 minutes of ADH administration.

Thirst is activated at a slightly higher osmolarity threshold (~290 mOsm) than ADH release, creating a safety margin: the kidney can concentrate urine and conserve water before the conscious drive to drink is engaged. Angiotensin II is the most potent dipsogenic substance known, stimulating thirst via the subfornical organ. This coupling ensures that RAAS activation (indicating volume depletion) simultaneously drives water ingestion to accompany the sodium retention mediated by aldosterone.

The interaction between volume and osmolarity regulation produces clinically important syndromes. In the syndrome of inappropriate ADH secretion (SIADH), ADH is released independently of osmotic or volume stimuli (e.g., from a small cell lung carcinoma, or as a drug side effect). The kidney retains water in excess of solute, plasma osmolarity falls, and hyponatraemia develops. The appropriate renal response to hypo-osmolarity would be to excrete free water (suppress ADH and produce dilute urine), but in SIADH the ADH signal is constitutively active and the kidney cannot escape it. Treatment requires fluid restriction, V2 receptor antagonists (conivaptan, tolvaptan), or addressing the underlying cause.

Conversely, in central diabetes insipidus, the posterior pituitary fails to secrete ADH. The collecting duct is impermeable to water, the kidney produces 15-20 litres of dilute urine per day, and plasma osmolarity rises unless the patient drinks commensurately. In nephrogenic diabetes insipidus, ADH is secreted normally but the kidney cannot respond — either because of a V2 receptor mutation (X-linked) or an aquaporin-2 mutation (autosomal), or because of acquired tubular damage (lithium toxicity, hypercalcaemia, obstructive nephropathy). Distinguishing central from nephrogenic diabetes insipidus requires measuring the response to administered desmopressin (a synthetic ADH analogue): in central diabetes insipidus, urine osmolarity rises appropriately; in nephrogenic diabetes insipidus, it does not.

Renal pharmacology: diuretic mechanisms and their physiological consequences [Master]

Diuretics are drugs that increase urine output by inhibiting specific sodium reabsorptive transporters at defined nephron sites. The physiological consequences of each diuretic class follow directly from the segmental transport architecture described above, and understanding diuretics at the mechanistic level provides a rigorous test of whether the segmental model has been internalised.

Carbonic anhydrase inhibitors (acetazolamide) block the enzyme carbonic anhydrase in the proximal tubule, both the membrane-bound isoform IV on the apical surface and the cytosolic isoform II inside the cell. Without carbonic anhydrase, the dehydration of to and in the lumen (and the rehydration reaction inside the cell) proceeds at its uncatalysed rate, which is slow relative to the rate of filtrate delivery. Bicarbonate reabsorption is therefore impaired, and the excess bicarbonate is delivered downstream as an osmotic load that limits water reabsorption. The natriuresis is modest because downstream segments (particularly the thick ascending limb) can increase their sodium reabsorption to compensate. The clinical consequence is a mild hyperchloraemic metabolic acidosis (because bicarbonate is lost and chloride is retained).

Loop diuretics (furosemide, bumetanide, torsemide) block the Na-K-2Cl cotransporter NKCC2 in the thick ascending limb. This abolishes the single effect of the counter-current multiplier, collapses the medullary osmotic gradient, and eliminates the kidney's ability to concentrate or dilute urine. The result is a massive natriuresis and diuresis — loop diuretics are the most potent diuretics available and are therefore called "high-ceiling" diuretics. Because NKCC2 blockade eliminates the lumen-positive transepithelial potential in the thick ascending limb, paracellular calcium and magnesium reabsorption is also impaired, leading to hypercalciuria and hypermagnesaemia. Loop diuretics also increase renal prostaglandin synthesis (by preventing the NaCl load at the macula densa from generating the tubuloglomerular feedback signal), which contributes to their potency and explains why NSAIDs (which block prostaglandin synthesis) attenuate the diuretic effect.

Thiazide diuretics (hydrochlorothiazide, chlorthalidone) block the Na-Cl cotransporter NCC in the distal convoluted tubule. The natriuresis is modest (the distal tubule handles only about 10% of filtered sodium). A distinctive effect of thiazides is that they decrease urinary calcium excretion — the opposite of loop diuretics. The mechanism involves increased passive paracellular calcium reabsorption in the distal tubule driven by the enhanced sodium gradient created when NCC is blocked and intracellular sodium falls. This hypocalciuric effect makes thiazides the pharmacological treatment of choice for calcium-based kidney stones. Thiazide diuretics also cause potassium depletion (by increasing sodium delivery to the collecting duct, where the increased sodium reabsorption via ENaC drives potassium secretion via ROMK) and can precipitate hyponatraemia in susceptible patients (by impairing free water excretion through an incompletely understood mechanism involving ADH sensitisation).

Potassium-sparing diuretics act on the collecting duct and include two subclasses. Aldosterone antagonists (spironolactone, eplerenone) competitively block the mineralocorticoid receptor, preventing aldosterone from upregulating ENaC and Na+/K+ ATPase. ENaC blockers (amiloride, triamterene) directly close the epithelial sodium channel from the luminal side. Both subclasses reduce sodium reabsorption and potassium secretion in the collecting duct, producing a mild natriuresis while preventing potassium loss. Spironolactone is used in heart failure not primarily for its diuretic effect but because blocking aldosterone reduces cardiac fibrosis and remodelling — a benefit demonstrated by the RALES trial (1999) that changed heart-failure management.

Osmotic diuretics (mannitol) are freely filtered at the glomerulus but are neither reabsorbed nor secreted by the tubule. Their osmotic presence in the tubular fluid opposes water reabsorption throughout the nephron, particularly in the proximal tubule and descending limb of the loop of Henle. Mannitol also increases medullary blood flow, washing out the osmotic gradient. The net effect is a large-volume diuresis with near-isosmotic urine. Mannitol is used clinically to reduce intracranial pressure (by creating an osmotic gradient that draws water out of the brain) and to prevent acute kidney injury in rhabdomyolysis (by flushing myoglobin through the tubules).

The hormonal responses to diuretic therapy illustrate the feedback complexity of volume regulation. Loop diuretics and thiazides both activate the RAAS (because the volume contraction they produce is sensed as a reduction in effective circulating volume), which stimulates aldosterone-mediated potassium secretion. This secondary hyperaldosteronism is the primary reason that potassium supplementation or potassium-sparing diuretics are co-prescribed with loop and thiazide diuretics. The "diuretic braking phenomenon" — the observation that the natriuretic response to a diuretic diminishes over days of continued administration — reflects this RAAS activation plus compensatory upregulation of sodium transporters in downstream nephron segments that are not blocked by the diuretic.

Connections [Master]

  • Osmosis and membrane transport 17.02.02 underpin all renal tubular transport. Water movement follows osmotic gradients established by active sodium transport; ion movement uses channels, cotransporters, exchangers, and active pumps described in the cell biology membrane transport unit. The proximal tubule's coupling of sodium reabsorption to glucose, amino acid, and bicarbonate recovery via secondary active transport is the central instance of the membrane-transport principles in a mammalian organ system.

  • Acid-base chemistry 14.10.01 provides the foundation for understanding renal acid-base regulation. The Henderson-Hasselbalch equation applied to the bicarbonate buffer system predicts how the kidneys maintain blood pH at 7.40. The three renal mechanisms — bicarbonate reabsorption, titratable acid formation, and ammonium excretion — each depend on the proton-buffer chemistry described in the acid-base unit.

  • Cardiovascular physiology 18.02.01 determines renal perfusion pressure, which drives glomerular filtration. Cardiac output and blood pressure regulation are intimately connected to renal function through the RAAS: the kidney is both a sensor of blood pressure (via the juxtaglomerular apparatus) and an effector (via sodium retention and renin release), creating a closed feedback loop with the cardiovascular system.

  • Endocrine hormones 18.07.01 regulate virtually every aspect of renal function: ADH controls water reabsorption via aquaporin-2, aldosterone controls sodium reabsorption via ENaC and Na+/K+ ATPase, parathyroid hormone controls calcium and phosphate handling via effects on the distal tubule and proximal tubule, and erythropoietin stimulates red blood cell production in response to renal hypoxia sensing.

Historical & philosophical context [Master]

William Bowman (1842) [Bowman 1842] described the anatomical relationship between the glomerular capillaries and the capsule that bears his name, establishing the glomerulus as the site where blood meets the urinary space. His work was purely anatomical; the functional question of whether the glomerulus filters or secretes remained unresolved for nearly a century.

Ernest Starling (1896) [Starling 1896] formulated the forces governing fluid exchange across capillary walls — the balance of hydrostatic and oncotic pressures now called Starling forces — which apply directly to glomerular filtration. Starling's insight was that capillary fluid exchange is a physical process governed by measurable forces, not a vitalistic function of the capillary wall. When applied to the glomerulus, Starling's framework predicts that the relatively high glomerular capillary hydrostatic pressure (maintained by the interposition of the efferent arteriole between the glomerular and peritubular capillary beds) drives filtration against the opposing oncotic pressure of the plasma proteins.

A. N. Richards, working in the 1930s [Richards 1938], used micropuncture techniques to sample fluid from individual nephron segments in living frogs and later mammals, demonstrating for the first time that glomerular filtrate is an ultrafiltrate of plasma (identical in non-protein composition) and that tubular reabsorption selectively modifies its composition along the nephron. This was the experimental proof that resolved the filtration-versus-secretion debate in favour of the filtration-reabsorption model that had been proposed by Carl Ludwig in the 1840s but lacked experimental support.

The counter-current mechanism was proposed by Werner Kuhn and colleagues in the 1950s [Kuhn & Ramel 1959], applying principles from chemical engineering (counter-current heat exchangers and distillation columns) to biological fluid processing. This cross-disciplinary insight — recognising that the same mathematics describing industrial separation processes applies to the kidney — is one of the earliest examples of quantitative systems biology and set the template for later mathematical physiology approaches.

The RAAS was characterised through the work of Tigerstedt and Bergman (1898, discovering renin) [Tigerstedt & Bergman 1898], Braun-Menendez and Page (1930s-40s, independently discovering angiotensin), Skeggs and colleagues (1956, identifying the ACE step), and Simpson and Tait (1953, isolating aldosterone). The complete enzymatic cascade — from renin through angiotensinogen, angiotensin I, ACE, angiotensin II, and aldosterone — was not fully mapped until the late 1960s and early 1970s. The development of ACE inhibitors in the 1970s (from the observation that snake venom peptides inhibited ACE) and their introduction as antihypertensive drugs in the 1980s represents one of the most successful translations of basic renal physiology into clinical practice.

Philosophically, renal physiology embodies the concept of homeostasis — a term coined by Walter Cannon in 1926 — more completely than any other organ system. The kidney maintains the constancy of the internal environment across a wide range of inputs and demands: variable water intake, variable salt intake, acid loads from metabolism, alkaline loads from vomiting, osmotic loads from diabetes, and haemodynamic challenges from haemorrhage or heart failure. Each disturbance activates a specific combination of sensors (volume receptors, osmoreceptors, baroreceptors, chemoreceptors) and effectors (ADH, aldosterone, ANP, renin, sympathetic tone) that restore the regulated variable toward its set point. This multi-loop feedback architecture, operating simultaneously on volume, osmolarity, potassium, acid-base, and calcium-phosphate balance, illustrates Cannon's principle that physiological regulation is fundamentally about maintaining stable internal conditions despite external variation.

Bibliography [Master]

  • Bowman, W., "On the structure and use of the Malpighian bodies of the kidney", Phil. Trans. Roy. Soc. 132 (1842), 57-80.
  • Starling, E. H., "On the absorption of fluids from the connective tissue spaces", J. Physiol. 19 (1896), 312-326.
  • Richards, A. N., "Processes of urine formation", Proc. Roy. Soc. B 126 (1938), 398-432.
  • Kuhn, W. & Ramel, A., "Aktiver Salztransport als moeglicher (und wahrscheinlicher) Einzeleffekt bei der Harnkonzentrierung in der Niere", Helv. Chim. Acta 42 (1959), 628-660.
  • Tigerstedt, R. & Bergman, P. G., "Niere und Kreislauf", Skand. Arch. Physiol. 8 (1898), 223-271.
  • Pitts, R. F., Physiology of the Kidney and Body Fluids, 3rd ed. (Year Book Medical Publishers, 1974).
  • Brenner, B. M. & Rector, F. C., The Kidney, 11th ed. (Elsevier, 2019).
  • Boron, W. F. & Boulpaep, E. L., Medical Physiology, 3rd ed. (Elsevier, 2017), Ch. 33-40.
  • Guyton, A. C. & Hall, J. E., Textbook of Medical Physiology, 14th ed. (Elsevier, 2020), Ch. 25-31.
  • Weinstein, A. M., "Mathematical models of renal fluid and electrolyte transport: acknowledging our uncertainty", Am. J. Physiol. Renal Physiol. 304 (2013), F871-F884.
  • Layton, H. E. & Layton, A. T., "A method for generating numerical solutions to a model of the urine concentrating mechanism", Bull. Math. Biol. 67 (2005), 1167-1191.
  • Cannon, W. B., "Organization for physiological homeostasis", Physiol. Rev. 9 (1929), 399-431.